摘要
目的观察脑血疏口服液联合阿托伐他汀治疗慢性硬膜下血肿术后患者的临床疗效。方法选取慢性硬膜下血肿患者68例,根据治疗方法不同分为观察组与对照组,观察组38例,对照组30例,2组均采取钻孔引流术,对照组单用阿托伐他汀治疗,观察组采用脑血疏口服液联合阿托伐他汀治疗。对比2组治疗效果、Barthel指数(BI)评分、格拉斯哥昏迷评分(GCS)、日常生活能力量表(ADL)评分、残余血肿量及术后疗效。结果对照组总有效率80.0%,观察组为97.0%,2组比较差异有统计学意义(P<0.05)。结论脑血疏口服液联合阿托伐他汀对慢性硬膜下血肿术后患者有显著疗效,能改善患者神经功能及生活质量。
Objective To observe the clinical effect of Naoxueshu oral liquid combined with atorvastatin in the treatment of chronic subdural hematoma.Methods 68 patients with chronic subdural hematoma were selected retrospectively.According to the different treatment methods,they were divided into the observation group and the control group.38 patients in the observation group and 30 patients in the control group.Both groups were treated with atorvastatin alone on the basis of borehole drainage.The observation group was treated with Naoxueshu oral liquid combined with atorvastatin.The treatment effect,Barthel index(BI),Glasgow coma score(GCS),ADL,residual hematoma volume and postoperative effect were compared between the two groups.Results The total effective rate was 80.0%in the control group and 97.0%in the observation group.There was significant difference between the two groups(P<0.05).Conclusion Naoxueshu oral liquid combined with atorvastatin has significant effect on patients with chronic subdural hematoma after surgery,and can improve neurological function and quality of life.
作者
郭晖
王沛
张慧娟
常琳涵
张越林
GUO Hui;WANG Pei;ZHANG Huijuan;CHANG Linhan;ZHANG Yuelin(Xi’an Medcial University,Xi’an 710021,China;Shaanxi Provincial People’s Hospital,Xi’an 710068,China)
出处
《中国实用神经疾病杂志》
2020年第10期839-843,共5页
Chinese Journal of Practical Nervous Diseases
基金
陕西省重点研发项目(编号:2017ZDXM-SF-25-2)。
关键词
慢性硬膜下血肿
阿托伐他汀
脑血疏口服液
钻孔引流术
术后
Chronic subdural hematoma
Atorvastatin
Naoxueshu oral liquid
Borehole drainage
Postopreation
